Singapore: A consortium consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, Ch...
Singapore: China biotech firm, Sinovac Biotech, has reported a decline of 31.6 percent in the first quarter of 2015, clo...
Singapore: Sinovac Dalian, subsidiary of China's Sinovac Biotech, has received China Food and Drug Administration approv...
Singapore: North China Pharmaceutical, ChinaChairman: Mr Yang HaijingRevenue: $1470 mnBusiness: Manufacturer and dist...
Singapore: In a bid to improve the healthcare scenario of Fiji islands, the country's health minister Mr Jone Usamate ha...
Singapore: GE Healthcare Life Sciences, an unit of GE Healthcare, will build KUBio modular biopharmaceutical factory in ...
Singapore: SHENZHEN NEPTUNUS BIOENGINEERING, ChinaRevenue: $1533.1 mnChairman: Mr Simin ZhangBusiness: Manufacturer o...
Singapore: With a view to cash-in on the huge demand for medical expertise in China, home-grown healthcare company Asian...
When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...
Singapore: In an effort to eliminate the weak industry oversight, the US drug regulatory body, the Food and Drug Adminis...
Singapore: In a new trend, Chinese drugmakers have been hiring Indian scientists, with a view to boost the country's for...
Singapore: China based healthcare product supplier, Nutrastar International, has marked revenue of $13.24 million in thr...
WuXi Healthcare Ventures announced the closing of its $290 million WuXi Healthcare Ventures II,exceeding its initial tar...
While both India and China - both have a billion plus population - present similar pictures in terms of opportunities an...
Singapore: China's WuXi AppTec has partnered with Fudan University to bring WuXi NextCODE's population human genomics da...
Singapore: The findings are surprising, mentions BVGH, as often it is the big pharmaceutical companies that invest larg...
There are very few manufacturers in Asia capable of manufacturing antibodies on a large commercial scale. Manufacturing ...
Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 mill...
